• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新的“coN”分期系统结合了淋巴结转移和肿瘤沉积,为 III 期结肠癌的 TNM 分期提供了更准确的预后。

The new 'coN' staging system combining lymph node metastasis and tumour deposit provides a more accurate prognosis for TNM stage III colon cancer.

机构信息

Department of General Surgery, Xiangya Hospital, Central South University, Changsha, People's Republic of China.

Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, People's Republic of China.

出版信息

Cancer Med. 2023 Feb;12(3):2538-2550. doi: 10.1002/cam4.5099. Epub 2022 Aug 1.

DOI:10.1002/cam4.5099
PMID:35912894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9939212/
Abstract

OBJECTIVE

Despite controversy over its origin and definition, the significance of tumour deposit (TD) has been underestimated in the tumour node metastasis (TNM) staging system for colon cancer, especially in stage III patients. We aimed to further confirm the prognostic value of TD in stage III colon cancer and to establish a more accurate 'coN' staging system combining TD and lymph node metastasis (LNM).

METHODS

Information on stage III colon cancer patients with a definite TD status was retrospectively collected from the Surveillance, Epidemiology and End Results (SEER) database between 2010 and 2017. The effect of TD on prognosis was estimated using Cox regression analysis. Maximally selected rank statistics were used to select the optimal cut-off value of TD counts. The predictive power of conventional N staging and the new coN staging was evaluated and compared by Akaike's information criterion (AIC), Harrell's concordance index (C-index) and time-dependent receiver operating characteristic (ROC) curves. Clinicopathological data of stage III colon cancer patients in the Xiangya database from 2014 to 2018 were collected to validate the coN staging system.

RESULTS

A total of 39,185 patients with stage III colon cancer were included in our study: 38,446 in the SEER cohort and 739 in the Xiangya cohort. The incidence of TD in stage III colon cancer was approximately 30% (26% in SEER and 30% in the Xiangya database). TD was significantly associated with poorer overall survival (OS) (HR = 1.37, 95% CI 1.31-1.44, p < 0.001 in SEER). The optimal cut-off value of TD counts was 4, and the patients were classified into the TD0 (count = 0), TD1 (count = 1-3) and TD2 (count ≥ 4) groups accordingly. The estimated 5-year OS was significantly different among the three groups (69.4%, 95% CI 68.8%-70.0% in TD0; 60.5%, 95% CI 58.9%-62.2% in TD1 and 42.6%, 95% CI 39.2%-46.4% in TD2, respectively, p < 0.001). The coN system integrating LNM and TD was established, and patients with stage III colon cancer were reclassified into five subgroups (coN1a, coN1b, coN2a, coN2b and coN2c). Compared with conventional N staging, the coN staging Cox model had a smaller AIC (197097.581 vs. 197358.006) and a larger C-index (0.611 vs. 0.601). The AUCs of coN staging at 3, 5 and 7 years were also greater than those of conventional N staging (0.6305, 0.6326, 0.6314 vs. 0.6186, 0.6197, 0.6160). Concomitant with the SEER cohort results, the coN staging Cox model of the Xiangya cohort also had a smaller AIC (2883.856 vs. 2906.741) and a larger C-index (0.669 vs. 0.633). Greater AUCs at 3, 5 and 7 years for coN staging were also observed in the Xiangya cohort (0.6983, 0.6774, 0.6502 vs. 0.6512, 0.6368, 0.6199).

CONCLUSIONS

Not only the presence but also the number of TDs is associated with poor prognosis in stage III colon cancer. A combined N staging system integrating LNM and TD provides more accurate prognostic prediction than the latest AJCC N staging in stage III colon cancer.

摘要

目的

尽管肿瘤沉积(TD)的起源和定义存在争议,但在结肠癌的肿瘤淋巴结转移(TNM)分期系统中,TD 的意义一直被低估,尤其是在 III 期患者中。我们旨在进一步证实 TD 在 III 期结肠癌中的预后价值,并建立一种更准确的“coN”分期系统,将 TD 与淋巴结转移(LNM)相结合。

方法

回顾性收集 2010 年至 2017 年期间来自 Surveillance, Epidemiology and End Results(SEER)数据库的 III 期结肠癌患者的 TD 状态信息。使用 Cox 回归分析评估 TD 对预后的影响。使用最大选择秩统计选择 TD 计数的最佳截止值。通过 Akaike 信息准则(AIC)、Harrell 一致性指数(C-index)和时间依赖性接受者操作特征(ROC)曲线评估和比较传统 N 分期和新的 coN 分期的预测能力。收集 2014 年至 2018 年来自湘雅数据库的 III 期结肠癌患者的临床病理数据,以验证 coN 分期系统。

结果

共纳入 39185 例 III 期结肠癌患者:SEER 队列 38446 例,湘雅队列 739 例。III 期结肠癌的 TD 发生率约为 30%(SEER 为 26%,湘雅数据库为 30%)。TD 与总生存期(OS)显著相关(HR=1.37,95%CI 1.31-1.44,p<0.001)。TD 计数的最佳截止值为 4,患者分为 TD0(计数=0)、TD1(计数=1-3)和 TD2(计数≥4)三组。三组之间的 5 年 OS 差异有统计学意义(TD0 组为 69.4%,95%CI 68.8%-70.0%;TD1 组为 60.5%,95%CI 58.9%-62.2%;TD2 组为 42.6%,95%CI 39.2%-46.4%,p<0.001)。建立了整合 LNM 和 TD 的 coN 系统,并将 III 期结肠癌患者重新分为五组(coN1a、coN1b、coN2a、coN2b 和 coN2c)。与传统 N 分期相比,coN 分期 Cox 模型的 AIC 更小(197097.581 vs. 197358.006),C-index 更大(0.611 vs. 0.601)。coN 分期在 3、5 和 7 年的 AUC 也大于传统 N 分期(0.6305、0.6326、0.6314 vs. 0.6186、0.6197、0.6160)。与 SEER 队列结果一致,湘雅队列的 coN 分期 Cox 模型的 AIC 也更小(2883.856 vs. 2906.741),C-index 更大(0.669 vs. 0.633)。coN 分期在 3、5 和 7 年的 AUC 也在湘雅队列中更大(0.6983、0.6774、0.6502 vs. 0.6512、0.6368、0.6199)。

结论

TD 的存在和数量都与 III 期结肠癌的不良预后相关。整合 LNM 和 TD 的 N 分期系统比最新的 AJCC N 分期在 III 期结肠癌中提供了更准确的预后预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ac/9939212/3bc9d6706195/CAM4-12-2538-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ac/9939212/6c9f28afcac2/CAM4-12-2538-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ac/9939212/8d7fbda4607b/CAM4-12-2538-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ac/9939212/2491d26c6c41/CAM4-12-2538-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ac/9939212/413791cbe31b/CAM4-12-2538-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ac/9939212/3bc9d6706195/CAM4-12-2538-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ac/9939212/6c9f28afcac2/CAM4-12-2538-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ac/9939212/8d7fbda4607b/CAM4-12-2538-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ac/9939212/2491d26c6c41/CAM4-12-2538-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ac/9939212/413791cbe31b/CAM4-12-2538-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ac/9939212/3bc9d6706195/CAM4-12-2538-g003.jpg

相似文献

1
The new 'coN' staging system combining lymph node metastasis and tumour deposit provides a more accurate prognosis for TNM stage III colon cancer.新的“coN”分期系统结合了淋巴结转移和肿瘤沉积,为 III 期结肠癌的 TNM 分期提供了更准确的预后。
Cancer Med. 2023 Feb;12(3):2538-2550. doi: 10.1002/cam4.5099. Epub 2022 Aug 1.
2
[Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].[Ⅲ期结肠癌中肿瘤结节TNM分期方法的预后价值及初步探索性研究]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Dec 25;22(12):1152-1158. doi: 10.3760/cma.j.issn.1671-0274.2019.12.010.
3
Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance).将肿瘤沉积物与淋巴结转移数相结合,以提高 III 期结肠癌的预后准确性:CALGB/SWOG 80702 期 III 研究(Alliance)的事后分析。
Ann Oncol. 2021 Oct;32(10):1267-1275. doi: 10.1016/j.annonc.2021.07.009. Epub 2021 Jul 20.
4
Prognostic accuracy of different lymph node staging system in predicting overall survival in stage IV colon cancer.不同淋巴结分期系统在预测 IV 期结肠癌总生存中的预后准确性。
Int J Colorectal Dis. 2020 Feb;35(2):317-322. doi: 10.1007/s00384-019-03486-w. Epub 2019 Dec 20.
5
Revised Nodal Staging Integrating Tumor Deposit Counts With Positive Lymph Nodes in Patients With Stage III Colon Cancer.修订后的淋巴结分期系统:将肿瘤沉积计数与 III 期结肠癌患者的阳性淋巴结相结合。
Ann Surg. 2023 Apr 1;277(4):e825-e831. doi: 10.1097/SLA.0000000000005355. Epub 2021 Dec 23.
6
Evaluation of the prognostic performance of different cutoff values of lymph node ratio staging system for stage III colorectal cancer.评估不同淋巴结比值分期系统截断值在 III 期结直肠癌中的预后性能。
Updates Surg. 2024 Aug;76(4):1311-1320. doi: 10.1007/s13304-024-01770-1. Epub 2024 Mar 26.
7
Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study.肿瘤沉积对 III 期结肠癌患者预后的意义:列线图研究。
J Surg Res. 2020 Jan;245:475-482. doi: 10.1016/j.jss.2019.07.099. Epub 2019 Aug 22.
8
Clinical significance of metastatic tumor deposit foci in rectal cancer in the lateral pelvic lymph node area.直肠癌侧方盆壁淋巴结转移瘤灶的临床意义。
Int J Clin Oncol. 2023 Oct;28(10):1388-1397. doi: 10.1007/s10147-023-02391-1. Epub 2023 Jul 22.
9
Prognostic value of a modified pathological staging system for gastric cancer based on the number of retrieved lymph nodes and metastatic lymph node ratio.基于淋巴结检出数和转移淋巴结比例的改良胃癌病理分期系统的预后价值。
PeerJ. 2024 Oct 1;12:e18165. doi: 10.7717/peerj.18165. eCollection 2024.
10
Reconsidering the prognostic significance of tumour deposit count in the TNM staging system for colorectal cancer.重新考虑肿瘤沉积计数在结直肠癌 TNM 分期系统中的预后意义。
Sci Rep. 2020 Jan 9;10(1):89. doi: 10.1038/s41598-019-57041-2.

引用本文的文献

1
LncRNA MIR99AHG serves as a diagnostic marker for early lung cancer and regulates cancer cell growth and metastasis via miR-194-5p.长链非编码RNA MIR99AHG作为早期肺癌的诊断标志物,并通过miR-194-5p调控癌细胞的生长和转移。
Discov Oncol. 2025 Jun 10;16(1):1050. doi: 10.1007/s12672-025-02896-3.
2
Discriminating Tumor Deposits From Metastatic Lymph Nodes in Rectal Cancer: A Pilot Study Utilizing Dynamic Contrast-Enhanced MRI.鉴别直肠癌中肿瘤沉积物与转移性淋巴结:一项利用动态对比增强磁共振成像的初步研究
Korean J Radiol. 2025 May;26(5):400-410. doi: 10.3348/kjr.2024.0767. Epub 2025 Mar 21.
3
Validated Integration of Tumor Deposits in N Staging for Prognostication in Colon Cancer.
肿瘤沉积物在结肠癌 N 分期中用于预后评估的验证整合
JAMA Surg. 2025 Apr 1;160(4):408-414. doi: 10.1001/jamasurg.2024.6729.
4
Negative prognostic impact of tumor deposits in stage III colorectal cancer patients.肿瘤沉积对 III 期结直肠癌患者的预后有负面影响。
PLoS One. 2024 Sep 26;19(9):e0310327. doi: 10.1371/journal.pone.0310327. eCollection 2024.